| (1) |
Mazzaferri EL. Management of a solitary thyroid nodule.
N Engl J Med. 1993; 328: 553-559. |
| (2) |
Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR.
Long-term follow up of patients with benign thyroid fine-needle aspiration
cytologic diagnoses. Surgery. 1989; 106: 980-986. |
| (3) |
Gharib H, Goellner JR. Fine-needle aspiration biopsy
of the thyroid: an appraisal. Ann Intern Med. 1993; 118: 282-289. |
| (4) |
Ross D. Thyroid hormone suppressive therapy of sporadic
nontoxic goiter. Thyroid. 1992; 2: 263-269. |
| (5) |
Cooper DS. Thyroxine suppression therapy for benign
nodular disease. J Clin Endocrinol Metab. 1995; 80: 331-334. |
| (6) |
Huysmans DAKC, Hermus Ad RMM, Constens FHM, Barentsz
JO, Klopperborg PWC. Large, compressive goiters treated with radioiodine.
Ann Intern Med. 1994; 121: 757-762. |
| (7) |
Dulgeroff AJ, Hershman JM. Medical therapy for differentiated
thyroid carcinoma. Endocr Rev. 1994; 15: 500-515. |
| (8) |
DeGroot LJ, Kaplan EL, McMormick M, Strauss FH. Natural
history, treatment and course of papillary thyroid carcinoma. J Clin
Endocrinol Metab. 1990; 71: 414-424. |
| (9) |
Hay ID. Papillary thyroid carcinoma. Endocrinol Metab
Clin North Am. 1990; 19: 545-576. |
| (10) |
Mazzaferri EL, Jhiang SM. Long-term impact of initial
surgical and medical therapy on papillary and follicular thyroid cancer.
Am J Med. 1994; 97: 418-428. |
| (11) |
Mazzaferri EL, Young RL. Papillary thyroid carcinoma:
a 10 year follow up report of the impact of therapy in 576 patients. Am
J Med. 1981; 70: 511-518. |
| (12) |
Wartofsky L. Use of sensitive TSH assay to determine
thyroid hormone therapy, avoid osteoporosis. Annu Rev Med. 1991;
42: 341-345. |
| (13) |
Biondi B, Fazio S, Carella C, et al. Cardiac effects
of long-term thyrotropin suppression with levothyroxine. J Clin Endocrinol
Metab. 1993; 77: 334-338. |
| (14) |
Barsano CP, Skosey C, DeGroot LJ, Refetoff S. Serum
thyroglobulin in the management of patients with thyroid cancer. Arch
Intern Med. 1982; 142: 763-767. |
| (15) |
Ozata M, Suzuki S, Miyamoto T, Liu TR, Fierro-Renoy
F, DeGroot LJ. Serum thyroglobulin in the follow up of patients with treated
differentiated thyroid cancer. J Clin Endocrinol Metab. 1994; 79:
98-105. |
| (16) |
Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular
thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med.
1980; 21: 733-737. |
| (17) |
Simpson WJ, Panzarella T, Caruthers JS, Gospodarowicz
MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment
in 1578 patients. Int J Radiat Oncol Biol Phys. 1988; 14: 1063-1075. |
| (18) |
Moley JF. Medullary thyroid cancer. Surg Clin North
Am. 1995; 75: 405-420. |
| (19) |
Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG,
Gagel RF. Applications of genetic screening information to the management
of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Endocrinol Metab Clin North Am. 1996; 25: 1-25. |
| (20) |
Nel CJC, van Heerden JA, Goellner JR, et al. Anaplastic
carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo
Clin Proc. 1985; 60: 51-58. |
| (21) |
Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical
aspects of primary thyroid lymphoma: diagnosis and treatment based on our
experience of 119 cases. Thyroid. 1993; 3: 93-98. |